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Abstract: Triticale (ˆ Triticosecale Whitm.) is a cereal grain with high levels of alkyresorcinols (AR)
concentrated in the bran. These phenolic lipids have been shown to reduce or inhibit triglyceride
accumulation and protect against oxidation; however, their biological effects have yet to be evaluated
in vivo. The purpose of this study was to determine the effects of ARs extracted from triticale bran
(TB) added to a high–fat diet on the development of obesity and oxidative stress. CF-1 mice were
fed a standard low-fat (LF) diet, a 60% high-fat diet (HF) and HF diets containing either 0.5% AR
extract (HF-AR), 10% TB (HF-TB), or 0.5% vitamin E (HF-VE). Energy intake, weight gain, glucose
tolerance, fasting blood glucose (FBG) levels, and body composition were determined. Oxygen
radical absorbance capacity (ORAC), superoxide dismutase (SOD) activity, and glutathione (GSH)
assays were performed on mice liver and heart tissues. The findings suggest that ARs may serve as a
preventative measure against risks of oxidative damage associated with high-fat diets and obesity
through their application as functional foods and neutraceuticals. Future studies aim to identify
the in vivo mechanisms of action of ARs and the individual homologs involved in their favorable
biological effects.
Keywords: Triticosecale; triticale bran; alkylresorcinols; body composition; glucose tolerance;
antioxidant activity; oxidative stress; magnetic resonance imaging (MRI); obesity
1. Introduction
The rising incidence rate of obesity has become a serious public health concern, resulting in a
growing consumer demand for a healthy diet by means of natural, health-promoting products [1,2].
Obesity is a disorder associated with an increased risk of numerous diseases including type II diabetes
and cardiovascular disease (CVD). Studies suggest that the co-morbidities in obesity are a result of
oxidative stress as a chief underlying source [3]. Oxidative stress is an imbalance in reactive oxygen
species (ROS) production that overwhelms the body’s antioxidant defense system. This defense system
includes both enzymatic and nonenzymatic mechanisms to neutralize and detoxify ROS and reactive
intermediates [4,5]. Some of the major contributors to this system are superoxide dismutase (SOD),
which catalyzes the conversion of highly reactive superoxide (O2´) molecules into a less reactive
product, hydrogen peroxide (H2O2). Enzymes glutathione peroxidase (GPx) and catalase can further
neutralize H2O2 by decomposition into water and oxygen. Antioxidant enzymes rely on endogenous
antioxidants such as glutathione (GSH) for the hydrogen and electron donations necessary for the
reduction and detoxification of ROS [5]. Fat accumulation correlates with oxidative stress, as evidenced
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by increases in ROS production, the ratio of oxidized glutathione to reduced glutathione (GSSG/GSH),
and NADPH oxidase expression, as well as a decrease in antioxidant enzyme expression in the adipose
tissue of obese mice [6].
Whole grain consumption is associated with a variety of health benefits including a reduced
risk of obesity and related diseases. Whole grains are rich in nutrients and phytochemicals, which
have been linked to the improvements seen in terms ofantioxidant protection, weight loss, BMI, and
blood-lipid metabolism in subjects fed a diet rich in whole grains [7–9]. The health-related functionality
of whole grains is principally due to the presence of bioactive compounds in the bran. Some of these
health benefits may be attributed to alkylresorcinols (ARs), bioactive compounds present almost
exclusively in the bran. These phenolic lipids possess a polar aromatic ring and a hydrophobic alkyl
chain, generally at the C5 position. Hydroxyl groups are attached to the aromatic ring at C1 & C3
and may serve as sources of ARs’ radical scavenging activity through hydrogen donation [10]. Due to
similarities in structural properties, ARs are often compared to vitamin E (tocopherols), which is a
well-established antioxidant [11], and studies have reported similarities in their metabolism after
ingestion [10,12,13]. ARs have also been shown to reduce or inhibit triglyceride accumulation [14],
in addition to their anti-inflammatory properties [15] and antioxidant protection [16]. In a recent study
by Oishi et al., mice fed a 28% fat and 20% sucrose diet showed positive physiological effects when
their diet was also supplemented with ARs (0.4% wheat bran ARs) in comparison to mice fed the
same diet lacking ARs [17]. Researchers found that the incorporation of ARs in the diet suppressed
the risks of obesity and glucose intolerance generally associated with a high fat, high sucrose diet
by increasing insulin sensitivity and cholesterol excretion. This is one of very few studies that have
investigated the physiological effects of ARs. Nonetheless, the antioxidant potential of ARs in vivo is
a question that remains inconclusive and has yet to be evaluated. Thus, the objective of this study
was to determine the effects of AR extracts from triticale bran (TB) added to a high–fat diet on the
development of obesity and oxidative stress.
2. Materials and Methods
2.1. Chemicals and Reagents
Acetone was purchased from Caledon Laboratories Ltd. (Georgetown, ON, Canada).
Alkylresorcinol standards were ordered from ReseaChem GmbH (Burgdorf, Switzerland).
Potassium phosphate buffer (KPi) was purchased from Mallinckrodt (Paris, KY, USA). Fluorescein,
Trolox, 2,21-azobis(2-methylpropionamidine)dihydrochloride (AAPH), super oxide dismutase,
manganese(II) chloride (MnCl2), 5,51-dithiobis-(2-nitrobenzoic acid) (DTNB), glutathione reductase
(GR), and 2-vinylpyridine (VP) were purchased from Sigma-Aldrich (Oakville, ON, Canada).
Ethylenediaminetetraacetic acid (EDTA), sulfosalicylic acid (SA), glutathione (GSH), bovine serum
albumin (BSA), nicotinamide adenine dinucleotide (NADH), 2-mercaptoethanol (MeSH), and
nicotinamide adenine dinucleotide phosphate (NADPH) were purchased from BioShop (Burlington,
ON, Canada). Oxidized glutathione (GSSG) was purchased from Santa Cruz Biotechnology (Dallas,
TX, USA).
2.2. Sample Preparation and Analysis
Triticale bran (TB) was provided by Agriculture and Agri-Food Canada (Lethbridge, Alberta).
Bran was milled to a 2 mm particle size prior to extraction using a Thomas Wiley Mill (model ED-5,
Arthur H. Thomas Co., Philadelphia, PA, USA). Complete methods of extraction, characterization, and
quantification of ARs were followed in accordance with our previous studies [18]. Alkylresorcinols
were extracted from TB for 24 h with acetone, at a 1:40 solid-to-solvent ratio (w/v; g/mL). The extracted
solution had all acetone removed by rotary evaporation using a BüchiRotavapor R-215 (New Castle,
DE, USA). The dried product was weighed and stored at ´20 ˝C prior to use.
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An Alliance HPLC system e2695 Separation Module with a photodiode array detector from
Waters (Milford, MA, USA) equipped with a reverse-phase C18 column (150 ˆ 4.6 mm, 5 µm) and
Empower 3 software was used for analysis. AR sample extracts and standards (C15:0, C17:0, C19:0,
C21:0, C23:0, and C25:0) were prepared in methanol and concentrations were determined according to
the calibration curve (0.125 to 2 mg/mL) of each standard. The method of HPLC analysis was modified
from Gunenc et al. [19] to separate and quantify the total AR content and homolog composition present
in our extract. A gradient system using 4% acetic acid in water (Solvent A) and 1% acetic acid in
methanol (Solvent B) was applied at a flow rate of 1 mL/min, with a column temperature of 35 ˝C
and an injection volume of 10 µL. The gradient system used initiated at 90% B for 10 min, followed by
100% B for 30 min, and returned to 90% B for a final 10 min.
2.3. Animals and Diets
The study protocol was approved by the Local Ethics Committee at Carleton University and all
experimental procedures complied with the Canadian Council on Animal Care (CCAC) guidelines.
Male CF-1 mice (~six weeks old; n = 40) were obtained from Charles River Laboratories (St. Constant,
QC, Canada). Throughout the entirety of the study, mice were maintained on a standard 12 h light dark
cycle (lights on at 08:00). Mice were allowed to acclimatize to vivarium conditions for one week, during
which time they were left undisturbed with ad libitum access to water supply and conventional chow
(2014 Teklad Global 14% Protein Rodent Maintenance Diet, Harlan Laboratories, Mississauga, ON,
Canada). Following this habituation period, a two-week baseline period was carried out in which mice
continued to be fed the same conventional chow with their food intake and body weight measures
recorded daily. Subsequently, animals were randomly assigned to one of five groups (n = 8 per group),
each of which were fed different diets for a period of 10 experimental weeks. Groups were categorized
by diet exposure type as follows: (A) low-fat conventional chow for maintenance; (B) high-fat TD.06414
from Harlan Laboratories; (C) high-fat containing 0.5% Vitamin E (5 g/kg feed); (D) high-fat containing
0.5% AR extract (5 g/kg feed); and (E) high-fat containing 10% TB (100 g/kg feed) with groups
designated LF, HF, HF-VE, HF-AR, and HF-TB respectively. The compositions of the control LF and
HF diets are shown in Table 1.
Table 1. Composition of the control diets.
Ingredient Low-Fat Diet High-Fat Diet
Carbohydrate (%) 48.0 27.3
Protein (%) 14.3 23.5
Fat (%) 4.0 34.3
Saturated (%) 0.7 12.7
Monounsaturated (%) 0.8 16.1
Polyunsaturated (%) 2.5 5.5
Fibre (%) 22.1 6.5
Soluble (%) 4.1 ´
Insoluble (%) 18.0 6.5
Energy density (kcal/g) 2.9 5.1
Energy from carbohydrate (%) 67.3 21.3
Energy from protein (%) 20.1 18.4
Energy from fat (%) 12.6 60.3
Body weight and food intake were recorded daily. The total duration of the study was 12 weeks
and at the end of this period, mice were fasted for 12 h prior to sacrifice by decapitation. Blood glucose
levels were measured at time of death using a Contour® next EZ Blood Glucose Monitoring System
(Bayer Inc., Toronto, ON, Canada) and organs were stored at ´80 ˝C immediately after being removed.
2.4. Glucose Tolerance Test (GTT)
During the experimental period, a glucose tolerance test was carried for all groups by
intraperitoneal (IP) injection of 20% D-glucose solution to overnight- fasted animals (12 h fast). Blood
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samples were collected from the tail vein and glucose levels measured by Contour Blood Glucose
Monitor at time 0 (prior to injection), 15, 30, 60, and 120 min after injection to determine the rate of
reduction of glucose level. The dose of glucose solution administered was 0.5% (0.5 mL/100 g) of the
mouse’s total body weight.
2.5. Carcass Analysis
Magnetic resonance imaging (MRI) was carried out courtesy of Health Canada using an
EchoMRI4in1TM mouse composition analyzer (EchoMRI, Houston, TX, USA) to measure the %
body fat and % lean fat of the decapitated animal carcasses.
2.6. Tissue Preparation
Dissected liver and heart tissues were fixed in solution at a ratio of 1:5 (w/v; g/mL), homogenized
using a Tissuemiser 130 V 50/60 HZ, 125 W (Fisher Scientific, Ottawa, ON, Canada), centrifuged at
12,000 g for 15 min at 4 ˝C, and the supernatant was collected and stored at ´80 ˝C until analysis
ensued. Tissue samples used for GSH assays were homogenized in ice-cold 5% SA that had been
briefly bubbled in nitrogen gas. Samples used for SOD and ORAC assays were homogenized in a
solution of 100 mM potassium phosphate buffer solution (pH 7.5) with 1 mM EDTA.
2.7. Protein Determination
Protein levels were determined based on the method proposed by Bradford M.M. [20], using
bovine serum albumin as a standard. Absorbance was read at 595 nm using a SpectraMax 340PC384
microplate reader (Molecular Devices, Sunnyvale, CA, USA).
2.8. Antioxidant Activity Assays
2.8.1. Oxygen Radical Absorbance Capacity (ORAC) Assay
ORAC assays were carried out with minor modifications of procedures previously described by
us [18]. All solutions were prepared in 100 mM potassium phosphate buffer (pH 7.5) which was also
used as the blank. Varying concentrations of Trolox (a water-soluble vitamin E analog) were used as
standard to create a reference range. Fluorescence was measured using an automated plate reader
(FLx800 with Gen5 software, BioTek Instruments, Winooski, VT, USA) for a total runtime of 90 min,
at excitation and emission wavelengths of 485 and 525 nm. Final results were calculated as Trolox
equivalents per mg of protein.
2.8.2. Super Oxide Dismutase (SOD) Activity
The activity of SOD in tissue samples was measured indirectly by monitoring the inhibition of
superoxide-induced NADH oxidation, seen as a decrease in absorbance at 340 nm over a period of
10 min [21]. The following solutions (10 µL each) were added sequentially to a 96-well plate: 50 mM
EDTA, 25 mM MnCl2 , 2.7 mM NADH, and 50 µL of supernatant (6–8 different concentrations), blank
(100 mM KPi), or standard (1 µg/mL SOD). The reaction was initiated by the final addition of 39 mM
MeSH. One unit of SOD activity represents the amount of enzyme in the sample that inhibits NADH
oxidation reaction by 50%. Results are expressed in U of SOD/mg of protein.
2.8.3. Gluatathione (GSH) Assay
The assay for glutathione followed procedures similar to those previously described by
Griffith O. W. [22]. It is based on the reaction of GSH with DTNB to produce a yellow end-product
that absorbs at 412 nm. Thus the concentration of GSH in the sample is dependent on the rate of TNB
production. To measure total GSH, the following solutions were sequentially added to a 96-well plate:
0.55 mM NADPH (100 µL), 1.32 mM DTNB (10 µL), sample, standard or blank (10 µL), and 11 U/mL
GR (10 µL). Ice-cold 5% SA was used as a blank and to prepare GSH standard solutions (1.25, 2.5, 5,
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10, and 20 µM). To determine the amount of GSSG within the samples, samples (50 µL) and a stock
solution of GSSG standard (50 µL) were individually treated with 60 µL of a 1:90 solution containing
VP and 500 mM KPi (v/v). This process derivatizes GSH in order to quantify GSSG levels exclusive
of GSH within the sample. In a separate 96-well plate, pre-treated samples were run against a GSSG
standard curve (0.1, 0.2, 0.4, 0.7, 1, 1.5, and 2.0 µM) following the aforementioned procedure for total
GSH. In determining total GSH, and GSSG, the actual concentration of GSH can be deduced using the
following formula:
Total “ GSH ` 2GSSG.
2.9. Statistical Analysis
Three of the mice, one from group LF (n = 7) and two from HF (n = 6), died prior to the end of the study
period, thus all data obtained from these mice have been excluded from the final results and statistical
analyses. All experiments and analyses were performed at least in triplicate. Results are presented as
means˘ SEM. Data were statistically analyzed by one-way analysis of variance (ANOVA) followed by
Duncan’s multiple range test (DMRT). Means were considered significantly different at p < 0.05.
3. Results
3.1. Characterization of ARs Extracts from TB
The compositions of total ARs and individual homologues in triticale bran are shown in Table 2.
The total amount of ARs found in triticale bran was 143.29 mg/100 g of which saturated ARs make up
82.0% and homologue C21:0 was the most prevalent with a concentration of 39.76 mg/100 g.
Table 2. Total alkylresorcinol (AR) content and composition of homologues (mg/100 g) in extract from
triticale bran (TB) determined by HPLC.
AR Homologue (mg/100 g)
Saturated
5-n-heptadecylresorcinol C 15:0 1.06 ˘ 0.2
5-n-heptadecylresorcinol C 17:0 12.44 ˘ 0.5
5-n-nonadecanylresorcinol C 19:0 28.08 ˘ 0.3
5-n-heneicosylresorcinol C 21:0 39.76 ˘ 0.3
5-n-tricosylresorcinol C 23:0 20.33 ˘ 0.2
5-n-pentacosylresorcinol C 25:0 15.86 ˘ 0.1
Unsaturated 12.12 ˘ 0.2
Unknown 13.61 ˘ 0.6
Total 143.29 ˘ 0.3
Analyses were performed in triplicate and the results were expressed as mean ˘ SD.
3.2. Weight and Intake Parameters
During the two-week baseline period in which all five groups were fed the same chow diet,
groups showed similar means (p > 0.05) in weight (33.6–34.4 g), daily weight gain (0.15–0.22 g/day),
and energy intake (17.3–18.4 Kcal/day). After the 10-week treatment period, animals fed high-fat diets
were 21% heavier and exhibited a higher mean of daily weight gain (p < 0.05) compared to the standard
control group LF. No statistical differences were found in cumulative weight gain or body weight
among the HF treatment groups (HF-AR, HF-TB, HF-VE, and HF), as seen in Figure 1. Comparable
results were found for the difference in mean energy intake (p < 0.05) between control groups HF and
LF. On the other hand, the mean energy intake of groups HF and HF-TB was found to be significantly
higher than that of HF-AR and HF-VE groups (Figure 2A). To estimate differences in the ability of
ingested energy to be metabolized [23], metabolic efficiency (ME) across the 10-week treatment period
was calculated as follows:
ME “ energy intake{body weight gain.
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While a statistically significant difference cannot be seen, the HF-TB group exhibits a greater mean
metabolic efficiency of 99 Kcal/g of body weight 227 when compared to the 83 Kcal/g for control HF
animals (Figure 2B). Overall, the standard control group LF demonstrated the lowest mean values in
weight (44.3 g), daily weight gain (0.17 g), energy intake (16.8 Kcal), and greatest metabolic efficiency
(120.4 Kcal/g).
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Figure 1. Cumulative weight gain (A) and body weight after 10 experimental weeks (B). LF: group
fed standard low-fat diet; HF: group fed high-fat diet; HF-VE: group fed HF diet with 0.5% VE added;
HF-AR: group fed F diet ith 0.5% ARs extract added; HF-TB: group fed HF diet with 10% TB.
Bars represent mean ˘ SE. Data were statistically analyzed using one-way A OVA and D RT where
statistical differences (p < 0.05) are represented by different letters and * indicates statistical difference
from HF group.
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Figure 2. Energy consumption (A) and metabolic efficiency after 10 experimental weeks (B). LF: group
fed standard low fat diet; HF: group fed high-fat diet; HF-VE: group fed HF diet with 0.5% VE added;
HF-AR: group fed HF diet with 0.5% ARs extract added; HF-TB: group fed HF diet with 10% TB.
Bars represent mean ˘ SE. Data were statistically analyzed using o e-way ANOVA and DMRT where
statistical differences (p < 0.05) are repres nted by different lett rs.
3.3. Glucose Tolerance and Fasting Blood Glucose
Although differencs were not statistically significant, lower fasting blood glucose levels of animals
on the HF-AR diet (6.1 mM) than the remaining HF treatment groups (7.2–8.0 mM) and control LF
group (7.1 mM) are apparent in Figure 3. The results of the GTT seen in Figure 4A indicated no
significant difference among all five groups at 15, 30, and 120 min. At 0 min blood glucose levels were
significantly higher in the HF group, with no marked differences found between the remaining groups.
After 60 min, control LF mice exhibited a significantly lower drop in blood glucose than the HF control
and treatment groups, with the exception of HF-AR. At each of the time points throughout the GTT,
HF-AR mice had the lowest blood glucose levels among the HF groups. Results of the GTT at different
time points were used to calculate the area under the curve (AUC) in the glucose versus time graph.
Based on results of AUC (Figure 4B), mice fed HF alone had a significantly higher mean AUC (2146.5)
than that of mice fed the standard LF (1585.1). Among the HF groups, HF-AR had the lowest AUC
(1810.8) followed by HF-TB (1941.5), HF-VE (1976.0), and HF.
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3.4. Body Composition 
The values obtained for carcass analysis at the end of the experimental period are summarized 
in  Table  3. No  statistical  difference was  found  in %  fat  amongst  the HF  groups  irrespective  of 
treatment  received. However, HF‐TB had  the  least %  fat  (24.1%)  and  statistically highest %  lean 
muscle (72.9%) when compared with the remaining HF groups. These results depict a similar trend 
to  that  of  metabolic  efficiency  findings.  These  findings  suggest  that  incorporation  of  0.5%  AR 
extract  or  0.5%  vitamin  E  in  a  60%  high‐fat  diet  does  not  prevent  fat  accumulation;  however, 
incorporation  of  10%  TB may  improve metabolic  efficiency  and  promote  an  increase  in %  lean 
muscle. 
Table 3. Body composition of mice carcasses. 
Treatment 1  Weight (g) Fat (%) Lean Muscle (%) 
LF  36.60 ± 1.35 b 18.02 ± 1.00 b 75.90 ± 0.89 a 
HF  46.66 ± 1.06 a 27.00 ± 1.03 a 69.89 ± 1.35 c 
HF‐VE  45.17 ± 2.18 a 26.09 ± 0.63 a 70.87 ± 0.62 bc 
HF‐AR  45.83 ± 3.15 a 28.10 ± 1.92 a 67.79 ± 1.89 c 
HF‐TB  45.06 ± 2.32 a 24.14 ± 1.35 a 72.87 ± 1.43 ab 
Body composition data obtained by EchoMRI4in1TM and expressed as % of decapitated mouse carcass 
body weight. 1 LF: group fed standard low‐fat diet; HF: group fed high‐fat diet; HF‐VE: group fed HF diet 
with 0.5% VE added; HF‐AR: group fed HF diet with 0.5% ARs extract added; HF‐TB: group fed HF diet 
with 10% TB. Data are presented as mean ± SE. Data were statistically analyzed using one‐way ANOVA 
and DMRT where statistical differences among groups (p < 0.05) are represented by different letters. 
3.5. Oxygen Radical Absorbance Capacity (ORAC) 
The  ORAC  assay  showed  that  mice  fed  a  high‐fat  diet  demonstrated  poor  antioxidant 
protection  of  the  fluorescent  probe  from  peroxyl  radicals  generated  by APPH.  Liver  and  heart 
tissues of HF control mice were found to have the lowest ORAC values of 0.31 and 0.33 μmol TE/g 
of protein, respectively, among all the groups (Figure 5). Supplementation of the high‐fat diet with 
0.5% AR extract significantly improved antioxidant status (p < 0.05), as evidenced by much higher 
b
a
ab
ab
ab
0
500
1000
1500
2000
2500
LF HF HF‐VE HF‐AR HF‐TBG
TT
 ar
ea
 un
ce
r th
e c
ur
ve
 (A
U
C)
B
Figure 4. Results of glucose tolerance test (GTT) mean blood glucose levels at 0, 30, 60, 90 and 120 min
after intraperitoneal injection of glucose solution (A), and mean area under the curve of GTT graph (B).
LF: group fed stand r low fat diet; HF: group fed high-fat diet; HF-VE: group fed HF diet with
0.5% VE added; HF-AR: g ou fed HF diet with 0.5% ARs extract dd ; HF-TB: group fed HF diet
with 10% TB. Bars represent mean ˘ SE. Data were statistically analyzed using one-way ANOVA and
DMRT where statistical differences (p < 0.05) are represented by different letters. # indicates statistical
difference from the control group and * indicates statistical difference from HF group.
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3.4. Body Composition
The values obtained for carcass analysis at the end of the experimental period are summarized in
Table 3. No statistical difference was found in % fat amongst the HF groups irrespective of treatment
received. However, HF-TB had the least % fat (24.1%) and statistically highest % lean muscle (72.9%)
when compared with the remaining HF groups. These results depict a similar trend to that of metabolic
efficiency findings. These findings suggest that incorporation of 0.5% AR extract or 0.5% vitamin E in a
60% high-fat diet does not prevent fat accumulation; however, incorporation of 10% TB may improve
metabolic efficiency and promote an increase in % lean muscle.
Table 3. Body composition of mice carcasses.
Treatment 1 Weight (g) Fat (%) Lean Muscle (%)
LF 36.60 ˘ 1.35 b 18.02 ˘ 1.00 b 75.90 ˘ 0.89 a
HF 46.66 ˘ 1.06 a 27.00 ˘ 1.03 a 69.89 ˘ 1.35 c
HF-VE 45.17 ˘ 2.18 a 26.09 ˘ 0.63 a 70.87 ˘ 0.62 bc
HF-AR 45.83 ˘ 3.15 a 28.10 ˘ 1.92 a 67.79 ˘ 1.89 c
HF-TB 45.06 ˘ 2.32 a 24.14 ˘ 1.35 a 72.87 ˘ 1.43 ab
Body composition data obtained by EchoMRI4in1TM and expressed as % of decapitated mouse carcass body
weight. 1 LF: group fed standard low-fat diet; HF: group fed high-fat diet; HF-VE: group fed HF diet with 0.5%
VE added; HF-AR: group fed HF diet with 0.5% ARs extract added; HF-TB: group fed HF diet with 10% TB.
Data are presented as mean ˘ SE. Data were statistically analyzed using one-way ANOVA and DMRT where
statistical differences among groups (p < 0.05) are represented by different letters.
3.5. Oxygen Radical Absorbance Capacity (ORAC)
The ORAC assay showed that mice fed a high-fat diet demonstrated poor antioxidant protection
of the fluorescent probe from peroxyl radicals generated by APPH. Liver and heart tissues of HF
control mice were found to have the lowest ORAC values of 0.31 and 0.33 µmol TE/g of protein,
respectively, among all the groups (Figure 5). Supplementation of the high-fat diet with 0.5% AR
extract significantly improved antioxidant status (p < 0.05), as evidenced by much higher mean ORAC
values of 0.53 and 0.54 µmol TE/g of protein, respectively. Addition of 0.5% VE and 10% TB also
showed marked improvements of 25%–35% in the liver and 55%–65% in the heart compared to the
tissues of non-supplemented HF mice.
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w th 0.5% VE added; HF-AR: group fed HF diet with 0.5% ARs extract adde ; HF-TB: group fed HF
diet with 10% TB. Bars rep esent mean ˘ SE. Data were statistically analyzed using one-way ANOVA
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3.6. Superoxide Dismutase (SOD) Activity
Although ARs seemed to improve SOD activity levels by 30% when compared to control HF liver
tissues, this difference was not statistically significant (p > 0.05). The same was true for the remainder
of the groups such that the activity of the SOD enzyme increased by approximately 20% and 5% for
VE and TB supplemented mice, respectively (Figure 6). In order to quantify units of SOD per mg of
protein, differences in % inhibition of NADH oxidation must be observed at varying concentrations of
tissue assayed. For this reason, no quantifiable differences were found for the SOD activity in mice
heart tissues.
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Figure 6. Superoxide dismutase activity in liver tissue of mice. LF: group fed standard low-fat diet; HF:
group fed high-fat diet; HF-VE: group fed HF diet with 0.5% VE added; HF-AR: group fed HF diet
with 0.5% ARs extract added; HF-TB: group fed HF diet with 10% TB. Bars represent mean ˘ SE. Data
were statistically analyzed using one-way ANOVA and DMRT where no statistical differences among
groups were found (p > 0.05).
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3.7. Reduced Glutathione (GSH) Content
Liver and heart tissues of the control HF group exhibited decreased levels of reduced GSH
(0.47 µM and 0.20 GSH/mg of protein) and increased ratios of GSSG/GSH (0.41 and 0.51), respectively,
in comparison to control LF mice (0.69 and 0.32 µM GSH/mg of protein; 0.27 and 0.32 GSSG/GSH).
These results were expected since a high-fat diet is often correlated with increasing levels of ROS,
leading to oxidative stress [24]. Overall, liver and heart tissues from HF-TB and HF-AR mice had
significantly higher GSH levels and significantly lower ratios of GSSG/GSH (p > 0.05) in comparison
to mice fed the high-fat diet alone (Figure 7).
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HF: group fed high‐fat diet; HF‐VE: group fed HF diet with 0.5% VE added; HF‐AR: group fed HF 
diet with 0.5% ARs extract added; HF‐TB: group fed HF diet with 10% TB. Bars represent mean ± SE. 
Data were  statistically  analyzed using one‐way ANOVA  and DMRT where  statistical differences 
among groups (p < 0.05) are represented by different letters. 
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Figure 7. Reduced glutathione levels (A & C) and ratio of oxidized glutathione to reduced glutathione
(GSSG/GSH) in mice liver and heart tissues (B & D). LF: group fed standard low-fat diet; HF: group
fed high-fat diet; HF-VE: group fed HF diet with 0.5% VE added; HF-AR: group fed HF diet with 0.5%
ARs extract added; HF-TB: group fed HF diet with 10% TB. Bars represent mean ˘ SE. Data were
statistic lly analyzed using o e-way ANOVA and DMRT where statistical differences among groups
(p < 0.05) are repre ented by different le ters.
4. Discussion
4.1. Weight and Intake Parameters
An increasing number of studies have reported the beneficial effects of phenolic compounds and
bioactives in cereal grains on obesity. Phenolics such as anthocyanins, rutin, gallic acid, ferulic acid,
genestein, and tea catechins can induce apoptosis of adipocytes, inhibit trigycleride accumulation,
or regulate plasma lipids and cholesterol levels; these are some of the mechanisms that have been
identified in which phenolics can act against the prevalent disease [25,26]. In this study, neither AR
nor VE supplementation resulted in significant changes in body weight, composition, or metabolic
efficiency. Ross et al. [27] found coinciding results in which rats fed a basal diet supplemented with
4 g AR/kg feed for fourweeks showed no effects on final body or organ weights. Nonetheless, the
higher energy intake yet greater metabolic efficiency found for animals fed HF-TB compared to HF
alone indicates that consumption of TB did attenuate weight gain and enhance metabolism in some
respect, which is in agreement with existing literature [28,29].
4.2. Glucose Tolerance and Fasting Blood Glucose
An impaired glucose tolerance test and persistently high FBG levels are indicators of insulin
resistance and hyperglycemia, respectively; these conditions are often linked to obesity and diabetes.
Insulin resistance is the failure of cells to respond to insulin hormone signaling, leading to reduced
glucose uptake and hyperglycemia [23,30]. Although not statistically significant (p = 0.06), the addition
of ARs did improve glucose tolerance, as evidenced by a lower mean area under the curve. Additionally,
fasting blood glucose levels were significantly lower in mice fed HF-AR rather than HF alone. A recent
study by Magnusdottir et al. [31] discovered an association between the plasma C17:0/C21:0 AR
homolog ratio and increased insulin sensitivity in subjects with metabolic syndrome fed a diet rich
in whole grain rye. In examining the intestinal loops of anesthetized dogs administered a solution
of alkyresorcinol and insulin, Sealock et al. [32] found that alkylresorcinols and related compounds
promoted the absorption of insulin from the gastrointestinal tract and into the circulating bloodstream,
thereby significantly dropping blood glucose levels. Results of these studies suggest that ARs perhaps
interact with insulin in a synergistic manner, potentially enhancing the functionality of insulin and
its effectiveness in blood glucose clearance. Although further investigation is necessary to confirm
this prospect and understand its mechanism of action, ARs show promising results in terms of their
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potential to ameliorate the glucose intolerance and insulin sensitivity commonly associated with
obesity and diabetes [17].
4.3. Oxygen Radical Absorbance Capacity (ORAC)
The ORAC assay best represents antioxidant reactions within biological systems by providing a
controllable source of peroxyl radicals that react with a florescent probe, resulting in a non-fluorescent
product; antioxidant capacity is quantified by comparison of net AUC (relative fluorescence
units vs. time) to that of a known antioxidant, trolox [33]. The significantly higher ORAC levels in the
liver and heart tissues of mice fed a high-fat diet with 0.5% ARs confirms the literature results reporting
the in vitro antioxidant potential of these dynamic phenolic lipids [11,16,34–37]. It is speculated that the
amphiphilic nature of ARs carries out their antioxidant actions in a similar manner to that of tocopherols
by easily incorporating in cell lipid bilayers and providing protection against lipid peroxidation by
hydrogen atom transfer from hydroxyl groups of the phenol ring to peroxyl radicals, thereby forming
stable products [10].
4.4. Superoxide Dismutase (SOD) Activity
Superoxide dismutase is an enzyme that catalyzes the dismutation of superoxide (O2.´) radicals
into less reactive forms, hydrogen peroxide and oxygen. It is proposed that the superoxide anion can
initiate and terminate lipid peroxidation, thus SOD concentrations in mammalian cells are not easily
susceptible to change as enough SOD is expressed to predominantly suppress ROS imbalances linked
to superoxide [38]. Also, it is known that SOD is a strong antioxidant that out-competes the reactions
of O2.´ to protect the cell from its toxicity [39]. The supplementation of 0.5% antioxidants (ARs or VE)
with a high-fat diet did not significantly enhance SOD activity. However, the expected negative impact
on SOD activity associated with increased levels of metabolic stressors such as ROS due to a high-fat
diet [3] were also not statistically pronounced. The lack of pronounced effects on SOD activity, whether
negative or positive, is potentially due to the strength and self-sufficient nature of the SOD enzyme in
successfully suppressing superoxide linked chain reactions. Thus, is it theorized that for significant
changes in SOD activity to be apparent, the initiating source of oxidative stress must be substantially
stronger and present for a more prolonged period of time than that experienced by the high-fat fed
mice in this study. In the future, other antioxidant enzymes such as glutathione peroxidase and catalase
may be a more reliable measure of antioxidant effects in less extreme conditions of oxidative stress.
4.5. Reduced Glutathione (GSH) Contents
A chief contributor to the biological defense system against oxidative damage is the antioxidant
molecule glutathione, which is naturally synthesized in the body. In its reduced form, it directly
interacts with reactive oxygen and nitrogen species or acts as a cofactor for enzymes. In healthy
cells, glutathione is mainly in the reduced form and a rising ratio of oxidized to reduced glutathione
(GSSG/GSH) is a significant marker of oxidative stress [40]. The significant increase in GSH levels and
decrease in the ratio of GSSG/GSH in HF-AR liver and heart tissues suggest that a diet supplemented
with ARs may play a role in the recycling of GSSG back to its reduced form as GSH. Although the
mechanism of action requires further investigation, it would be presumed that ARs help increase
GSH levels by direct reduction of GSSG through hydrogen atom transfer/donation or by free radical
quenching, which indirectly helps maintain higher GSH levels. Since GSH has multiple roles in the
endogenous antioxidant defense system, it is likely that GSH cooperates with SOD in the removal
of free radicals [39]. This may explain the significant effects demonstrated by ARs on GSH, yet less
pronounced or undetectable effects on SOD activity in the liver and heart, respectively, as ARs may
only impact SOD activity indirectly through GSH.
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5. Conclusions
Cereal grains are rich in phenolics, predominantly in the bran fraction, which also contains
an abundance of other bioactive components that have been shown to protect against chronic
diseases including obesity and diabetes [41,42]. Although ARs did not impact weight gain and body
composition, results were promising in their ability to improve glucose tolerance and fasting blood
glucose levels. Additionally, ARs proved to have antioxidant potential in vivo through their enhanced
effects on oxidative stress markers, results that confirmed literature findings for the antioxidant
capacity of ARs demonstrated in vitro. Alkylresorcinols are known to be weaker antioxidants than
tocopherols based on in vitro studies [11]; however, results of this study demonstrate that several other
physiological factors are involved in vivo as ARs had an overall greater effect than VE in improving
oxidative stress as well as glucose tolerance. It has also been shown that AR chain length has an effect
on their in vivo elimination kinetics such that the half-life of ARs in rats was positively correlated with
alkyl chain length [43]. However, Korycinska et al. [11] found that chain length did not significantly
impact their antioxidant status. Thus, future studies aim to measure and compare the effects of
individual AR homologs in vivo. Also, the complex nature of the mechanisms involved in the body’s
antioxidant system requires further exploration to better understand the effects of antioxidant therapy
and apply these findings to preventative measures against oxidative stress and chronic diseases.
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